| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $694K | +1.0% |
| SG&A Expense | $366K | +35.1% |
| Operating Income | -$1.1M | -10.6% |
| Pre-tax Income | -$1.2M | -21.5% |
| Income Tax | $0 | — |
| Net Income | -$869K | -27.8% |
| EPS (Basic) | -$0.32 | -100.0% |
| EPS (Diluted) | -$0.32 | -100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32K | -66.7% |
| Current Assets | $103K | -21.4% |
| Total Assets | $307K | -45.0% |
| Total Liabilities | $3.8M | +18.9% |
| Stockholders' Equity | -$3.5M | -19.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$701K | -43.6% |
| Capital Expenditures | $3K | -98.9% |
| Investing Cash Flow | -$1K | -100.3% |
| Financing Cash Flow | $638K | +1495.0% |
| Free Cash Flow | -$704K | +7.0% |